Pravastatin, an HMG-CoA Reductase Inhibitor, Is Transported by Rat Organic Anion Transporting Polypeptide, oatp2
- 1 June 1999
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 16 (6) , 904-908
Abstract
Purpose. We previously demonstrated the HMG-CoA reductase inhibitor, pravastatin, is actively taken up into isolated rat hepatocytes through multispecific organic anion transporters. The present...Keywords
This publication has 28 references indexed in Scilit:
- Molecular Characterization and Tissue Distribution of a New Organic Anion Transporter Subtype (oatp3) That Transports Thyroid Hormones and Taurocholate and Comparison with oatp2Journal of Biological Chemistry, 1998
- Expression Cloning and Characterization of a Novel Multispecific Organic Anion TransporterJournal of Biological Chemistry, 1997
- Recent Advances in Carrier-mediated Hepatic Uptake and Biliary Excretion of XenobioticsPharmaceutical Research, 1996
- Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver.The Journal of Pharmacology and Experimental Therapeutics, 1996
- In Vivo and in Vitro Blood–Brain Barrier Transport of 3-Hydroxy-3-Methylglutaryl Coenzyme A (HMG-CoA) Reductase InhibitorsPharmaceutical Research, 1994
- Expression cloning of a rat liver Na(+)-independent organic anion transporter.Proceedings of the National Academy of Sciences, 1994
- Na(+)-independent multispecific anion transporter mediates active transport of pravastatin into rat liverAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1993
- Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAsNeuron, 1992
- Tissue-selective action of pravastatin due to hepatocellular uptake via a sodium-independent bile acid transporterBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1992
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988